Room 1001, Building 1, Jinxiumingcheng, Pingxi Street, Nanjing Avenue, Pingqiao District, Xinyang, Henan, China
SHANGHAI, March 7, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently available only in China.
Dr. Xuan Linli, Chief of Medical Oncology at Jiahui International Cancer Center, stands on the patient’s right. The patient’s daughter, nursing team, medical team, and caregivers are gathered together at Jiahui International Hospital.
The 70‑something patient had exhausted all standard lines of treatment at MD Anderson Cancer Center in the United States. His doctors recommended ivonescimab, the first approved PD‑1/VEGF bispecific antibody for solid tumors. After a video consultation in late November scheduled within a week of their initial inquiry, the family chose Jiahui International Cancer Center in Shanghai for its multidisciplinary expertise and U.S.‑trained Medical Oncology Chief Dr. XUAN Linli.
During treatment, the patient developed immune‑related complications requiring ICU care. The cancer center rapidly coordinated oncology, neurology, critical care, and expert input from ivonescimab principal investigator Dr. Zhou Caicun. His condition has since stabilized, with ongoing care focused on disease control.
As a tertiary international hospital partnered with Massachusetts General Hospital Cancer Center, Jiahui provides seamless international patient pathways, from remote consultations to travel coordination and continuous family updates.
The patient's daughter said, "We are deeply grateful for the dedication, compassion, and tireless efforts of the entire Jiahui team: the doctors, nurses, kitchen and cleaning staff, the international team and front desk, and the care aides. My father would especially like to express his heartfelt thanks to Ms. Cui, who has cared for him every day since his admission. Beyond her attentive bedside care, she has offered him encouragement, comfort, and hope."
China's breakthrough oncology innovations are creating new options for patients worldwide. JICC continues to draw growing inquiries and referrals from North America, Europe, Asia and the Middle East, establishing Shanghai as a global hub for advanced cancer care.
The full story: https://jiahui.com/en/news/181
Contact:
International Patient Services
internationaloffice@jiahui.com
WhatsApp: +852 4619 1904
Business zone:
Area: Sanya
Address: Room 1001, Building 1, Jinxiumingcheng, Pingxi Street, Nanjing Avenue, Pingqiao District, Xinyang, Henan, China
Jinhong Holiday Hotel (Xinyang Century Plaza) reserve:+8620-86009099
Busy or no answer, online booking please!
Catering Entertainment:+86-376-3576999
Meeting room reserve
Jinhong Holiday Hotel (Xinyang Century Plaza) address: Room 1001, Building 1, Jinxiumingcheng, Pingxi Street, Nanjing Avenue, Pingqiao District, Xinyang, Henan, China
锦鸿假日酒店(信阳世纪广场店) ◎ Jinhong Holiday Hotel (Xinyang Century Plaza)
Disclaimer: We are a tourism service provider that provides room booking services for Jinhong Holiday Hotel (Xinyang Century Plaza) We are not the official website of the hotel, please be aware.